Key facts
as of Sep 2026- Abridge’s last known valuation is $6.6B.
- It has raised $758.0M across 3 recorded rounds; the latest was Later Stage VC (Series D) ($250.0M) in Feb 2025.
- Notable investors include Andreessen Horowitz, Mana Ventures, Soma Capital, Khosla Ventures, Lightspeed Venture Partners — 50 tracked in total.
- Private Market View tracks 1 recorded secondary trades in Abridge shares.
- Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence~$165per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 50 names
- ·Watchlist + deal alerts for Abridge
Create free account
No card required
Recorded secondary trades
1 on record · Dec 2025 – Dec 20251 trades between Dec 2025 and Dec 2025. Exact dates, prices and structures are available to Pro members.
Dec 2025peak 1 prints / monthDec 2025
Counts and months are public. The prints are the product.Unlock 1 trade prints
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Abridge in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.
Funding rounds
3 roundsFeb 2025Later Stage VC (Series D)$250.0M▮
Feb 2024Later Stage VC (Series C)$150.0M▮
Oct 2023Later Stage VC (Series B)$30.0M▮
About Abridge
Developer of an AI-powered conversation analysis application designed to bring context and understanding to every medical conversation. The company's application uses machine learning to offer an audio-based system to record and summarize medical conversations, give insights and meaning to them, enabling users to follow through with the doctors' recommendations and to reduce administrative burden.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Software
- HQ
- Pittsburgh, PA, United States
- Founded
- 2018
- Employees
- 488
- Website
- abridge.com/
- Ownership
- Privately Held (backing)